Puerarin Activates Adaptive Autophagy and Protects the Myocardium Against Doxorubicin-Induced Cardiotoxicity Via the 14–3-3Γ/pkcε Pathway
Yian Peng,Liang Wang,Zeyu Zhang,Xinlan He,Qigui Fan,Xie Cheng,Yang Qiao,Huang,Songqing Lai,Qing Wan,Ming He,Huan He
DOI: https://doi.org/10.1016/j.biopha.2022.113403
IF: 7.419
2022-01-01
Biomedicine & Pharmacotherapy
Abstract:Doxorubicin (Dox)-induced cardiotoxicity (DIC) seriously threatens the health of related patients. Studies have confirmed that 14–3–3γ and protein kinase C epsilon (PKCε) are the endogenous protective proteins. Puerarin (Pue) is a bioactive ingredient isolated from the root of Pueraria lobata. It possesses many pharmacological properties, which have been widely used in treating and adjuvant therapy of cardiovascular diseases. In the study, we intended to explore the effects and mechanism of Pue pretreatment to protect the myocardium against DIC injury. Adult mice and H9c2 cells were pretreated with Pue, and the injury model was made with Dox. Results showed that Pue pretreatment alleviated DIC injury, as revealed by increased cell viability, decreased LDH activity and apoptosis, inhibited excess oxidative stress, maintained mitochondrial function and energy metabolism, and improved myocardial function. Furthermore, Pue pretreatment upregulated 14–3–3γ expression, interacted with PKCε, phosphorylated and impelled migration to mitochondria, activated adaptive autophagy, and protected the myocardium. However, pAD/14–3–3γ-shRNA or εV1–2 (a PKCε activity inhibitor) or 3-methyladenine (an autophagy inhibitor) could weaken the above effects of Pue pretreatment. Together, Pue pretreatment could activate adaptive autophagy by the 14–3–3γ/PKCε pathway and protect the myocardium against DIC injury.